Twist Bioscience Corporation (BIT:1TWST)
Italy
· Delayed Price · Currency is EUR 29.09
+1.43 (5.17%)
At close: May 12, 2025
Twist Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2019 |
| Net Income | -191.15 | -208.73 | -204.62 | -217.86 | -152.1 | -139.93 | Upgrade
|
| Depreciation & Amortization | 25.14 | 28.83 | 28.41 | 16.51 | 9.75 | 6.68 | Upgrade
|
| Other Amortization | 2.6 | 2.6 | 0.9 | - | - | 0.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -4.61 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 44.93 | 44.93 | 6.79 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.21 | Upgrade
|
| Stock-Based Compensation | 58.4 | 50.93 | 30.28 | 79.66 | 37 | 17.1 | Upgrade
|
| Other Operating Activities | 1.95 | 1.93 | -3.22 | 7.26 | 2.49 | -0.89 | Upgrade
|
| Change in Accounts Receivable | -14.22 | 8.44 | -4.32 | -9.62 | -2.2 | -14.27 | Upgrade
|
| Change in Inventory | 9.52 | 7.99 | 7.24 | -7.54 | -19.49 | -4.96 | Upgrade
|
| Change in Accounts Payable | 0.34 | -11.81 | -2.51 | 7.38 | 8.54 | -5.51 | Upgrade
|
| Change in Other Net Operating Assets | 6.37 | 10.79 | -1.42 | 4.42 | 3.77 | -0.44 | Upgrade
|
| Operating Cash Flow | -56.11 | -64.09 | -142.47 | -124.39 | -112.24 | -142.26 | Upgrade
|
| Capital Expenditures | -9.38 | -5.08 | -27.78 | -101.86 | -27.06 | -9.87 | Upgrade
|
| Cash Acquisitions | - | - | - | -8.16 | -0.48 | - | Upgrade
|
| Divestitures | - | - | - | -5.76 | - | - | Upgrade
|
| Investment in Securities | 4.42 | 2.01 | 78.39 | -117.16 | 183.7 | -104.78 | Upgrade
|
| Investing Cash Flow | -4.96 | -3.07 | 50.61 | -232.93 | 156.16 | -114.65 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -1.56 | -3.33 | -3.33 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -1.56 | -3.33 | -3.33 | Upgrade
|
| Issuance of Common Stock | 12.7 | 10.87 | 5.32 | 279.85 | 343.36 | 309.49 | Upgrade
|
| Repurchase of Common Stock | -0.03 | -3.98 | -4.41 | -7.75 | -10.85 | -2.42 | Upgrade
|
| Other Financing Activities | 15 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 27.68 | 6.89 | 0.91 | 270.53 | 329.18 | 303.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.13 | 0.13 | -0.03 | -0.32 | 0.02 | 0.02 | Upgrade
|
| Net Cash Flow | -33.27 | -60.15 | -90.98 | -87.1 | 373.11 | 46.85 | Upgrade
|
| Free Cash Flow | -65.49 | -69.17 | -170.25 | -226.24 | -139.31 | -152.12 | Upgrade
|
| Free Cash Flow Margin | -18.84% | -22.10% | -69.46% | -111.14% | -105.27% | -168.84% | Upgrade
|
| Free Cash Flow Per Share | -1.11 | -1.19 | -2.99 | -4.20 | -2.89 | -3.88 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.01 | 0.17 | 0.44 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.34 | 0.42 | 0.25 | 0.1 | 0.17 | Upgrade
|
| Levered Free Cash Flow | -16.89 | -17.44 | -112.43 | -160.52 | -73.09 | -83.46 | Upgrade
|
| Unlevered Free Cash Flow | -16.77 | -17.42 | -112.43 | -160.47 | -72.86 | -83.16 | Upgrade
|
| Change in Net Working Capital | -4.12 | -15.24 | 14.92 | -0.85 | -3.24 | 23.57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.